Search research articles
Contact Us
Filters
Showing results (51-60 of 84) with videos related to
Page
of 9
Sort By:
Communications Biology
|
March 3, 2026
Integrative structural insights into the IgG-FcRn interactions revealed by engineered FcRn-immobilized affinity chromatography
Masato Kiyoshi, Takuo Suzuki, Naruaki Inoue, et al.
Therapeutic Innovation & Regulatory Science
|
August 7, 2025
Temporal Trends in the Prescription of Biosimilars and the Status of Switching from Original Biologics to Biosimilars at Individual and Institutional Levels in Japan
Minako Matsumoto, Ryosuke Kumazawa, Akiko Ishii-Watabe, et al.
Scientific Reports
|
October 2, 2023
Specific peptide conjugation to a therapeutic antibody leads to enhanced therapeutic potency and thermal stability by reduced Fc dynamics
Masato Kiyoshi, Makoto Nakakido, Abdur Rafique, et al.
Biomaterials
|
March 30, 2004
The targeting of anionized polyvinylpyrrolidone to the renal system
Hiroshi Kodaira, Yasuo Tsutsumi, Yasuo Yoshioka, et al.
Biomaterials
|
September 22, 2009
The treatment of established murine collagen-induced arthritis with a TNFR1-selective antagonistic mutant TNF
Hiroko Shibata, Yasuo Yoshioka, Yasuhiro Abe, et al.
Biochemical and Biophysical Research Communications
|
October 10, 2007
Improved cytosolic translocation and tumor-killing activity of Tat-shepherdin conjugates mediated by co-treatment with Tat-fused endosome-disruptive HA2 peptide
Toshiki Sugita, Tomoaki Yoshikawa, Yohei Mukai, et al.
Cytokine
|
September 26, 2008
The therapeutic effect of TNFR1-selective antagonistic mutant TNF-alpha in murine hepatitis models
Hiroko Shibata, Yasuo Yoshioka, Akiko Ohkawa, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
December 24, 2025
Development of tCAP(N3): Affinity Peptide-Aided, pH-Triggered Strategy for Site-Specific Native IgG Modification
Hiroko Kawakami, Abdur Rafique, Shugo Tsuda, et al.
Journal of Pharmaceutical Sciences
|
February 27, 2026
Flow imaging for particle characterization and quantification in biologicals: A perspective from the Japanese Biopharmaceutical Consortium
Hiroko Shibata, Tim Menzen, Andrea Hawe, et al.
Journal of Biochemistry
|
April 24, 2009
Fast binding kinetics and conserved 3D structure underlie the antagonistic activity of mutant TNF: useful information for designing artificial proteo-antagonists
Yohei Mukai, Teruya Nakamura, Yasuo Yoshioka, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 84) with videos related to
Sort By:
Page
of 9
Communications Biology
|
March 3, 2026
Integrative structural insights into the IgG-FcRn interactions revealed by engineered FcRn-immobilized affinity chromatography
Masato Kiyoshi, Takuo Suzuki, Naruaki Inoue, et al.
Therapeutic Innovation & Regulatory Science
|
August 7, 2025
Temporal Trends in the Prescription of Biosimilars and the Status of Switching from Original Biologics to Biosimilars at Individual and Institutional Levels in Japan
Minako Matsumoto, Ryosuke Kumazawa, Akiko Ishii-Watabe, et al.
Scientific Reports
|
October 2, 2023
Specific peptide conjugation to a therapeutic antibody leads to enhanced therapeutic potency and thermal stability by reduced Fc dynamics
Masato Kiyoshi, Makoto Nakakido, Abdur Rafique, et al.
Biomaterials
|
March 30, 2004
The targeting of anionized polyvinylpyrrolidone to the renal system
Hiroshi Kodaira, Yasuo Tsutsumi, Yasuo Yoshioka, et al.
Biomaterials
|
September 22, 2009
The treatment of established murine collagen-induced arthritis with a TNFR1-selective antagonistic mutant TNF
Hiroko Shibata, Yasuo Yoshioka, Yasuhiro Abe, et al.
Biochemical and Biophysical Research Communications
|
October 10, 2007
Improved cytosolic translocation and tumor-killing activity of Tat-shepherdin conjugates mediated by co-treatment with Tat-fused endosome-disruptive HA2 peptide
Toshiki Sugita, Tomoaki Yoshikawa, Yohei Mukai, et al.
Cytokine
|
September 26, 2008
The therapeutic effect of TNFR1-selective antagonistic mutant TNF-alpha in murine hepatitis models
Hiroko Shibata, Yasuo Yoshioka, Akiko Ohkawa, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
December 24, 2025
Development of tCAP(N3): Affinity Peptide-Aided, pH-Triggered Strategy for Site-Specific Native IgG Modification
Hiroko Kawakami, Abdur Rafique, Shugo Tsuda, et al.
Journal of Pharmaceutical Sciences
|
February 27, 2026
Flow imaging for particle characterization and quantification in biologicals: A perspective from the Japanese Biopharmaceutical Consortium
Hiroko Shibata, Tim Menzen, Andrea Hawe, et al.
Journal of Biochemistry
|
April 24, 2009
Fast binding kinetics and conserved 3D structure underlie the antagonistic activity of mutant TNF: useful information for designing artificial proteo-antagonists
Yohei Mukai, Teruya Nakamura, Yasuo Yoshioka, et al.
Page
of 9